Nanovector-based therapies in advanced pancreatic cancer.
about
Onivyde for the therapy of multiple solid tumorsNanomedicine developments in the treatment of metastatic pancreatic cancer: focus on nanoliposomal irinotecanNanovectors for anti-cancer drug delivery in the treatment of advanced pancreatic adenocarcinomaSelection of pancreatic cancer cell-binding landscape phages and their use in development of anticancer nanomedicines.Targeted therapies for pancreatic adenocarcinoma: Where do we stand, how far can we go?Pancreatic cancer: current standards, research updates and future directionsA phase I dose-escalation study of PEP02 (irinotecan liposome injection) in combination with 5-fluorouracil and leucovorin in advanced solid tumors.Population Pharmacokinetics of Liposomal Irinotecan in Patients With Cancer.
P2860
Q26747166-E57DCAB0-B80D-4310-A19C-6168339EEA18Q26751368-909ED1BC-6387-42EF-9D72-522BCBB933C0Q28077206-829EE4C4-B781-44F2-8790-2AF63A4D6F6AQ31163147-44A05850-8256-4B4A-B890-E56B16B93896Q33361738-D703B3EF-DF89-4E68-92EC-E4DE09EE3E56Q36097184-A160EDB2-6937-44DA-AAB9-807C1E1F4446Q36200313-4BD8980E-25C7-47F0-A51A-DB5939864EF5Q49178301-A591CF5C-75AF-4B42-9EC9-B262AD9485FB
P2860
Nanovector-based therapies in advanced pancreatic cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Nanovector-based therapies in advanced pancreatic cancer.
@ast
Nanovector-based therapies in advanced pancreatic cancer.
@en
type
label
Nanovector-based therapies in advanced pancreatic cancer.
@ast
Nanovector-based therapies in advanced pancreatic cancer.
@en
prefLabel
Nanovector-based therapies in advanced pancreatic cancer.
@ast
Nanovector-based therapies in advanced pancreatic cancer.
@en
P2093
P2860
P1476
Nanovector-based therapies in advanced pancreatic cancer.
@en
P2093
Chang-Sung Tsai
John W Park
Li-Tzong Chen
P2860
P304
P356
10.3978/J.ISSN.2078-6891.2011.034
P577
2011-09-01T00:00:00Z